Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine versus fentanyl for pain control during percutaneous endoscopic debridement in infected necrotizing pancreatitis
ChiCTR2000033302Phase 4Recruiting
- Sponsor
- General Hospital of Eastern Military Command
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nalbuphine and fentanyl in Infected Pancreatic Necrosis (IPN) and acute pancreatitis (AP) (2 arms), sponsored by General Hospital of Eastern Military Command. Primary endpoint: Qualified rate of analgesia. Started Mar 2020; status: recruiting.
02
Drugs
nalbuphinefentanyl
03
Conditions
Infected Pancreatic Necrosis (IPN)acute pancreatitis (AP)
Beyond the preview
Go deeper on ChiCTR2000033302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033302.